207 related articles for article (PubMed ID: 26534874)
1. Randomized double-blind placebo-controlled trial of buccal misoprostol to reduce the need for additional uterotonic drugs during cesarean delivery.
Hernández-Castro F; López-Serna N; Treviño-Salinas EM; Soria-López JA; Sordia-Hernández LH; Cárdenas-Estrada E
Int J Gynaecol Obstet; 2016 Feb; 132(2):184-7. PubMed ID: 26534874
[TBL] [Abstract][Full Text] [Related]
2. Buccal misoprostol to prevent hemorrhage at cesarean delivery: a randomized study.
Hamm J; Russell Z; Botha T; Carlan SJ; Richichi K
Am J Obstet Gynecol; 2005 May; 192(5):1404-6. PubMed ID: 15902121
[TBL] [Abstract][Full Text] [Related]
3. Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss.
Chaudhuri P; Banerjee GB; Mandal A
Int J Gynaecol Obstet; 2010 Apr; 109(1):25-9. PubMed ID: 20070961
[TBL] [Abstract][Full Text] [Related]
4. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
Borruto F; Treisser A; Comparetto C
Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
[TBL] [Abstract][Full Text] [Related]
5. Sublingual misoprostol as an adjunct to oxytocin during cesarean delivery in women at risk of postpartum hemorrhage.
Chaudhuri P; Majumdar A
Int J Gynaecol Obstet; 2015 Jan; 128(1):48-52. PubMed ID: 25277789
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery.
Elbohoty AE; Mohammed WE; Sweed M; Bahaa Eldin AM; Nabhan A; Abd-El-Maeboud KH
Int J Gynaecol Obstet; 2016 Sep; 134(3):324-8. PubMed ID: 27350226
[TBL] [Abstract][Full Text] [Related]
7. Rectally administrated misoprostol as an alternative to intravenous oxytocin infusion for preventing post-partum hemorrhage after cesarean delivery.
Chaudhuri P; Mandi S; Mazumdar A
J Obstet Gynaecol Res; 2014 Sep; 40(9):2023-30. PubMed ID: 25181622
[TBL] [Abstract][Full Text] [Related]
8. Active Management of the Third Stage of Labor With a Combination of Oxytocin and Misoprostol to Prevent Postpartum Hemorrhage: A Randomized Controlled Trial.
Quibel T; Ghout I; Goffinet F; Salomon LJ; Fort J; Javoise S; Bussieres L; Aegerter P; Rozenberg P;
Obstet Gynecol; 2016 Oct; 128(4):805-11. PubMed ID: 27607864
[TBL] [Abstract][Full Text] [Related]
9. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.
Vimala N; Mittal S; Kumar S
Int J Gynaecol Obstet; 2006 Feb; 92(2):106-10. PubMed ID: 16343498
[TBL] [Abstract][Full Text] [Related]
10. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial.
Winikoff B; Dabash R; Durocher J; Darwish E; Nguyen TN; León W; Raghavan S; Medhat I; Huynh TK; Barrera G; Blum J
Lancet; 2010 Jan; 375(9710):210-6. PubMed ID: 20060161
[TBL] [Abstract][Full Text] [Related]
11. Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial.
King KJ; Douglas MJ; Unger W; Wong A; King RA
Anesth Analg; 2010 Dec; 111(6):1460-6. PubMed ID: 20889945
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage.
Chaudhuri P; Majumdar A
Int J Gynaecol Obstet; 2016 Feb; 132(2):191-5. PubMed ID: 26613819
[TBL] [Abstract][Full Text] [Related]
13. Carbetocin versus sublingual misoprostol plus oxytocin infusion for prevention of postpartum hemorrhage at cesarean section in patients with risk factors: a randomized, open trail study.
Elgafor el Sharkwy IA
Arch Gynecol Obstet; 2013 Dec; 288(6):1231-6. PubMed ID: 23689739
[TBL] [Abstract][Full Text] [Related]
14. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial.
Blum J; Winikoff B; Raghavan S; Dabash R; Ramadan MC; Dilbaz B; Dao B; Durocher J; Yalvac S; Diop A; Dzuba IG; Ngoc NT
Lancet; 2010 Jan; 375(9710):217-23. PubMed ID: 20060162
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial comparing 400μg sublingual misoprostol versus placebo for prevention of primary postpartum hemorrhage.
Zgaya R; Ghadhab I; Triki MA; Briki R
Pan Afr Med J; 2020; 36():186. PubMed ID: 32952830
[TBL] [Abstract][Full Text] [Related]
16. Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial.
Owonikoko KM; Arowojolu AO; Okunlola MA
J Obstet Gynaecol Res; 2011 Jul; 37(7):715-21. PubMed ID: 21375669
[TBL] [Abstract][Full Text] [Related]
17. Double-blind randomized controlled trial comparing misoprostol and oxytocin for management of the third stage of labor in a Nigerian hospital.
Musa AO; Ijaiya MA; Saidu R; Aboyeji AP; Jimoh AA; Adesina KT; Abdul IF
Int J Gynaecol Obstet; 2015 Jun; 129(3):227-30. PubMed ID: 25835642
[TBL] [Abstract][Full Text] [Related]
18. Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial.
Othman ER; Fayez MF; El Aal DE; El-Dine Mohamed HS; Abbas AM; Ali MK
Taiwan J Obstet Gynecol; 2016 Dec; 55(6):791-795. PubMed ID: 28040121
[TBL] [Abstract][Full Text] [Related]
19. Carbetocin versus rectal misoprostol for management of third stage of labor among women with low risk of postpartum hemorrhage.
Maged AM; Waly M; Fahmy RM; Dieb AS; Essam A; Salah NM; Hussein EA; Nabil H
Int J Gynaecol Obstet; 2020 Feb; 148(2):238-242. PubMed ID: 31736069
[TBL] [Abstract][Full Text] [Related]
20. Buccal misoprostol to decrease blood loss after vaginal delivery: a randomized trial.
Bhullar A; Carlan SJ; Hamm J; Lamberty N; White L; Richichi K
Obstet Gynecol; 2004 Dec; 104(6):1282-8. PubMed ID: 15572491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
